Life Sciences Companies Automating PV Data Capture?
The pressures on pharmaceutical organisations to capture, sift and process real-world adverse event data are immense - and soaring. So why are safety and pharmacovigilance departments lagging in their application of smart technology, wonders John Price, a life sciences regulatory and safety consultant and advisor to Arriello.